Jennifer A Lenz

11PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyPredictive and prognostic markersHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 11, 2025
Systemic STING agonist therapy drives expression of interferon stimulated genes and downstream production of cytokines in dogs with solid tumors.

Jennifer A Lenz, June DiBona, Matthew J Atherton

|Aug 04, 2025
Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers.

Dillon Didehvar, Jennifer A Lenz, Brandon Peng

|Jan 31, 2025
Maximizing the dual benefit of pet dogs in cancer trials.

Jennifer A Lenz, Matthew J Atherton

|Jan 03, 2025
Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma.

Jennifer A Lenz, Brandon Peng, Charles-Antoine Assenmacher

|Apr 08, 2024
Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog.

Dillon S Didehvar, Matthew R Lanza, Matthew J Atherton

Pageof 2